Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported a third-quarter loss of $24.2 million, after reporting a profit in the same period a year earlier.

Earlier this year, ANI Pharmaceuticals acquired Alimera Sciences for $5.50 per share in cash and one non-tradable contingent value right (CVR) of up to $0.50 per share upon achieving certain net ...